The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy

BACKGROUND/AIMS: Before tenofovir (TDF) become available in South Korea, combination therapy with entecavir (ETV) and adefovir (ADV) was the most potent regimen for chronic hepatitis B (CHB) patients who fail to respond to rescue therapy for drug resistance. We analyzed the efficacy of ETV-ADV combi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Mol Hepatol
Päätekijät: Kim, Jeong Han, Ahn, Sung Hyun, Ko, Soon Young, Choe, Won Hyeok, Kim, Kyun-Hwan, Kwon, So Young
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Korean Association for the Study of the Liver 2016
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946405/
https://ncbi.nlm.nih.gov/pubmed/27304549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2015.0053
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia